AirStrip Technologies has received a strategic investment from Qualcomm, acting through its Qualcomm Life Fund. Terms of the investment were not disclosed.
The Qualcomm Life Fund, an investment allocation of Qualcomm that is managed by Qualcomm Ventures, Qualcomm’s investment group, focuses on investments in venture-backed wireless health companies and start-ups that will help accelerate commercialization of wireless health technologies, such as the Qualcomm Life 2net Platform. Areas of specific interest range from personal wellness to disease management.
The AirStrip Technologies platform allows clinicians to securely access patient monitoring data such as continuous heart tracings and other waveforms – along with other physiologic parameters such as blood pressure, temperature, oxygen saturation, weight, and pulse – from EMRs, bedside monitors and devices, lab, and other clinical information systems. Physicians, nurses and case managers can view and interact with the information using a mobile device such as a smartphone or tablet. AirStrip solutions are FDA cleared, compliant with federal patient privacy standards and are CE Mark certified for sale in Europe and elsewhere.
AirStrip also recently announced in collaboration with Qualcomm Life, a Qualcomm wholly owned subsidiary that conducts Qualcomm’s wireless health business, a home health monitoring initiative that integrates the AirStrip patient monitoring solution with the Qualcomm 2net Platform.